Vehicle Intelligence System Market Projected to Reach USD 14-02-2023, 14:19

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

Imua Raises $5M Seed Round to Launch the AWS for Trust 25-02-2025, 06:00